DeepMed Research

University of Oxford

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Private

Established: 1096-01-01

Employees: 10K

Market Cap: -

Website: http://www.ox.ac.uk

Clinical Trials

Evaluation of Tak Community Advisory Board

Completed

Conditions: Community Members

Interventions: Other: Interviews and Focus Group Discussions

First Posted Date: 2012-11-01

Last Posted Date: 2018-09-10

Lead Sponsor: University of Oxford

Target Recruit Count: 20

Registration Number: NCT01719965

Locations: 🇹🇭
Shoklo Malaria Research Unit, Mae Sot, Tak, Thailand

SPK Study in Afghanistan

Not Applicable

Completed

Conditions: Uncomplicated P. Falciparum Malaria

Interventions: Drug: Artesunate + Sulphadoxine-pyrimethamine

First Posted Date: 2012-10-16

Last Posted Date: 2020-10-14

Lead Sponsor: University of Oxford

Target Recruit Count: 83

Registration Number: NCT01707199

Locations: 🇦🇫
Narang, Asadabad, Watapoor district health centres, Kunar, Afghanistan

Pictorial Representation of Illness and Self Measure

Completed

Conditions: Rheumatoid Arthritis

First Posted Date: 2012-10-16

Last Posted Date: 2019-04-30

Lead Sponsor: University of Oxford

Target Recruit Count: 220

Registration Number: NCT01707186

Locations: 🇬🇧
Nuffield Orthopaedic Centre, Oxford, United Kingdom

Safety Study of Tuberculosis Vaccines AERAS-402 and MVA85A

Phase 1

Completed

Conditions: Tuberculosis

Interventions: Biological: AERAS-402
Biological: MVA85A

First Posted Date: 2012-09-12

Last Posted Date: 2014-09-17

Lead Sponsor: University of Oxford

Target Recruit Count: 40

Registration Number: NCT01683773

Locations: 🇬🇧
Centre for Clinical Vaccinology and Tropical Medicine (CCVTM), Churchill Hospital, Oxford, Oxfordshire, United Kingdom
🇬🇧
The Wellcome Trust Clinical Research Facility (WTCRF), University of Birmingham, Birmingham, West Midlands, United Kingdom

ADITEC FLU STUDY: Understanding the Genetic Basis for Immune Responses

Phase 2

Completed

Conditions: Influenza

Interventions: Biological: ATIV (Fluad)
Biological: TIV (Aggripal)

First Posted Date: 2012-09-10

Last Posted Date: 2017-10-02

Lead Sponsor: University of Oxford

Target Recruit Count: 90

Registration Number: NCT01682369

Locations: 🇬🇧
Centre for Clinical Vaccinology & Tropical Medicine (CCVTM), Oxford, Oxfordshire, United Kingdom

D-cycloserine Augmented CBT for Panic Disorder

Phase 3

Terminated

Conditions: Panic Disorder

Interventions: Drug: d-cycloserine
Drug: placebo
Behavioral: cognitive-behaviour therapy

First Posted Date: 2012-09-06

Last Posted Date: 2018-05-03

Lead Sponsor: University of Oxford

Target Recruit Count: 33

Registration Number: NCT01680107

Locations: 🇬🇧
Department of Psychiatry, University of Oxford, Oxford, United Kingdom

Adjuvanting Viral Vectored Malaria Vaccines With Matrix M

Phase 1

Completed

Conditions: Malaria
Matrix M

Interventions: Biological: Standard Dose Matrix M Regimen
Biological: Low Dose Matrix M Regimen
Biological: Control Regimen

First Posted Date: 2012-08-21

Last Posted Date: 2015-01-07

Lead Sponsor: University of Oxford

Target Recruit Count: 23

Registration Number: NCT01669512

Locations: 🇬🇧
Centre for Clinical Vaccinology and Tropical Medicine, Oxford, Oxfordshire, United Kingdom

Pharmacokinetic and in Vitro Transmission Blocking Activities Study of Primaquine Compare to Methylene Blue in Healthy Volunteer Both G6PD Normal and G6PD Deficiency

Phase 1

Completed

Conditions: G6PD Deficient
Healthy
G6PD Normal

Interventions: Drug: Regimens (Primaquine, Methylene blue)

First Posted Date: 2012-08-20

Last Posted Date: 2015-11-03

Lead Sponsor: University of Oxford

Target Recruit Count: 20

Registration Number: NCT01668433

Locations: 🇹🇭
Hospital for Tropical Diseases, Bangkok, Thailand

Efficacy of Malaria Vaccines in Kenyan Adults

Phase 2

Completed

Conditions: Malaria

Interventions: Biological: ChAd63 ME-TRAP / MVA ME-TRAP prime-boost immunisation
Biological: Rabies vaccine

First Posted Date: 2012-08-16

Last Posted Date: 2013-12-12

Lead Sponsor: University of Oxford

Target Recruit Count: 120

Registration Number: NCT01666925

Locations: 🇰🇪
KEMRI/Wellcome Trust Programme, Centre for Geographic Medicine Research - Coast, Kilifi, Kenya

Efficacy of Candidate Malaria Vaccines in Senegalese Adults

Phase 2

Completed

Conditions: Malaria

Interventions: Biological: ChAd63 ME-TRAP and MVA ME-TRAP
Biological: Rabies vaccine

First Posted Date: 2012-08-07

Last Posted Date: 2013-12-12

Lead Sponsor: University of Oxford

Target Recruit Count: 120

Registration Number: NCT01658696

Locations: 🇸🇳
University Cheikh Anta Diop (UCAD), Dakar, Senegal

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy